Halaven.com

Visit halaven.com
  • 7 months ago

    Last scanned

  • 14 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Halaven.com

Visit halaven.com

Overal rating:

B9876A78-C14B-4F49-9F4B-396039336A47@1x

About Website

Updated:

HALAVEN® (eribulin mesylate) Injection: Treatment for Metastatic Breast Cancer (mBC)

Learn about HALAVEN® (eribulin mesylate), an injectable treatment for patients with third-line Metastatic Breast Cancer (mBC). See the full Indication and Important Safety Information for HALAVEN®.

Halaven.com thumbnail
Halaven.com thumbnail

Trustworthy

99E6BC28-40D1-4264-B66E-CBC423C983BF@1x

Network Data

This website is hosted with Fidelity National Information Services, Inc., which reserves the following IP addresses for halaven.com: 208.74.145.245. Moreover, DNS used with this website include ns-1504.awsdns-60.org, ns-1544.awsdns-01.co.uk, ns-206.awsdns-25.com, ns-897.awsdns-48.net. Subnet identifier ranges from 208.74.144.0 to 208.74.147.255. Classless Inter-Domain Routing (CIDR) is 208.74.144.0/22. ARIN net type is Direct Allocation.

  • 7 months ago

    Last scanned

  • 14 years

    Domain Age

  • No data

    Daily Visitors

  • No data

    Global Rank

Trustworthy

Network

ADDRESSING DETAILS

Whois

OWNERSHIP

Domain & Keywords

The registrar of halaven.com is 1API GmbH and the name expires on 2024-02-03. According to open source data, you can reach the owner at dommaster@mark-i.jp but please make sure you have a good reason for unsolicited messages. Their country of residence is Japan.

  • metastatic breast cancer
  • metastatic breast cancer treatment
  • halaven
  • eribulin
  • eribulin mesylate
  • eribulin package insert
  • advanced liposarcoma
  • unresectable liposarcoma
  • metastatic liposarcoma
  • metastatic breast cancer patient

Websites similar to halaven.com